glucagon has been researched along with Sarcopenia in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cai, X; Chen, C; Fan, Y; Lin, S; Ling, M; Yang, F | 1 |
| Adeva-Andany, MM; Carneiro-Freire, N; Castro-Calvo, I; Fernández-Fernández, C; López-Pereiro, Y | 1 |
1 review(s) available for glucagon and Sarcopenia
| Article | Year |
|---|---|
The effects of glucagon and the target of rapamycin (TOR) on skeletal muscle protein synthesis and age-dependent sarcopenia in humans.
Topics: Animals; Glucagon; Humans; Muscle Proteins; Muscle, Skeletal; Sarcopenia; Sirolimus | 2021 |
1 other study(ies) available for glucagon and Sarcopenia
| Article | Year |
|---|---|
Screening Potential Diagnostic Biomarkers for Age-Related Sarcopenia in the Elderly Population by WGCNA and LASSO.
Topics: Aged; AMP-Activated Protein Kinases; Biomarkers; Computational Biology; Databases, Genetic; Estrogens; Gene Expression Profiling; Gene Regulatory Networks; Glucagon; Humans; Insulins; Phospholipases; Sarcopenia | 2022 |